Notably, when adding TrxR into this combination panel, diagnostic efficiency for GC was further elevated (AUC 0.982; 95% CI, 0.970–0.993) relative to the combination of only CEA, CA19-9 and CA72-4 (P < 0.01). The gene discussed is CEACAM5; the disease is gastric cancer.